Annual FCF
-$119.51 M
-$2.74 M-2.34%
31 December 2023
Summary:
Tango Therapeutics annual free cash flow is currently -$119.51 million, with the most recent change of -$2.74 million (-2.34%) on 31 December 2023. During the last 3 years, it has fallen by -$188.48 million (-273.28%). TNGX annual FCF is now -273.28% below its all-time high of $68.97 million, reached on 31 December 2020.TNGX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$33.51 M
-$9.58 M-40.03%
30 September 2024
Summary:
Tango Therapeutics quarterly free cash flow is currently -$33.51 million, with the most recent change of -$9.58 million (-40.03%) on 30 September 2024. Over the past year, it has dropped by -$2.35 million (-7.56%). TNGX quarterly FCF is now -334.00% below its all-time high of -$7.72 million, reached on 30 June 2021.TNGX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$123.18 M
-$2.35 M-1.95%
30 September 2024
Summary:
Tango Therapeutics TTM free cash flow is currently -$123.18 million, with the most recent change of -$2.35 million (-1.95%) on 30 September 2024. Over the past year, it has dropped by -$2.06 million (-1.70%). TNGX TTM FCF is now -794.01% below its all-time high of -$13.78 million, reached on 31 March 2021.TNGX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TNGX Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.3% | -7.6% | -1.7% |
| 3 y3 years | -273.3% | -50.5% | -181.4% |
| 5 y5 years | - | - | - |
TNGX Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -273.3% | at low | -90.4% | +11.9% | -181.4% | at low |
| 5 y | 5 years | -273.3% | at low | -334.0% | +11.9% | -794.0% | at low |
| alltime | all time | -273.3% | at low | -334.0% | +11.9% | -794.0% | at low |
Tango Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$33.51 M(+40.0%) | -$123.18 M(+1.9%) |
| June 2024 | - | -$23.93 M(-37.1%) | -$120.82 M(-1.0%) |
| Mar 2024 | - | -$38.05 M(+37.4%) | -$122.03 M(+2.1%) |
| Dec 2023 | -$119.51 M(+2.3%) | -$27.69 M(-11.1%) | -$119.51 M(-1.3%) |
| Sept 2023 | - | -$31.15 M(+23.9%) | -$121.12 M(+7.3%) |
| June 2023 | - | -$25.14 M(-29.2%) | -$112.86 M(-6.8%) |
| Mar 2023 | - | -$35.53 M(+21.2%) | -$121.07 M(+3.7%) |
| Dec 2022 | -$116.77 M | -$29.31 M(+28.0%) | -$116.77 M(+11.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$22.89 M(-31.4%) | -$105.06 M(+0.6%) |
| June 2022 | - | -$33.35 M(+6.8%) | -$104.44 M(+32.5%) |
| Mar 2022 | - | -$31.23 M(+77.4%) | -$78.81 M(+28.4%) |
| Dec 2021 | -$61.36 M(-189.0%) | -$17.60 M(-21.0%) | -$61.36 M(+40.2%) |
| Sept 2021 | - | -$22.27 M(+188.4%) | -$43.77 M(+103.6%) |
| June 2021 | - | -$7.72 M(-44.0%) | -$21.50 M(+56.0%) |
| Mar 2021 | - | -$13.78 M | -$13.78 M |
| Dec 2020 | $68.97 M | - | - |
FAQ
- What is Tango Therapeutics annual free cash flow?
- What is the all time high annual FCF for Tango Therapeutics?
- What is Tango Therapeutics annual FCF year-on-year change?
- What is Tango Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Tango Therapeutics?
- What is Tango Therapeutics quarterly FCF year-on-year change?
- What is Tango Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Tango Therapeutics?
- What is Tango Therapeutics TTM FCF year-on-year change?
What is Tango Therapeutics annual free cash flow?
The current annual FCF of TNGX is -$119.51 M
What is the all time high annual FCF for Tango Therapeutics?
Tango Therapeutics all-time high annual free cash flow is $68.97 M
What is Tango Therapeutics annual FCF year-on-year change?
Over the past year, TNGX annual free cash flow has changed by -$2.74 M (-2.34%)
What is Tango Therapeutics quarterly free cash flow?
The current quarterly FCF of TNGX is -$33.51 M
What is the all time high quarterly FCF for Tango Therapeutics?
Tango Therapeutics all-time high quarterly free cash flow is -$7.72 M
What is Tango Therapeutics quarterly FCF year-on-year change?
Over the past year, TNGX quarterly free cash flow has changed by -$2.35 M (-7.56%)
What is Tango Therapeutics TTM free cash flow?
The current TTM FCF of TNGX is -$123.18 M
What is the all time high TTM FCF for Tango Therapeutics?
Tango Therapeutics all-time high TTM free cash flow is -$13.78 M
What is Tango Therapeutics TTM FCF year-on-year change?
Over the past year, TNGX TTM free cash flow has changed by -$2.06 M (-1.70%)